Education
About Us
Working with TipRanks
Follow Us
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
Total Valuation
Collegium Pharmaceutical has a market cap or net worth of $1.19B. The enterprise value is $1.87B.
Market Cap$1.19B
Enterprise Value$1.87B
Share Statistics
Collegium Pharmaceutical has 31,502,127 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding31,502,127
Owned by Insiders3.44%
Owned by Institutions0.68%
Financial Efficiency
Collegium Pharmaceutical’s return on equity (ROE) is 0.30 and return on invested capital (ROIC) is 9.77%.
Return on Equity (ROE)0.30
Return on Assets (ROA)0.04
Return on Invested Capital (ROIC)9.77%
Return on Capital Employed (ROCE)0.15
Revenue Per Employee1.77M
Profits Per Employee193.81K
Employee Count357
Asset Turnover0.38
Inventory Turnover7.15
Valuation Ratios
The current PE Ratio of Collegium Pharmaceutical is 37.0. Collegium Pharmaceutical’s PEG ratio is ―.
PE Ratio37.0
PS Ratio―
PB Ratio―
Price to Fair Value4.04
Price to FCF―
Price to Operating Cash Flow6.03
PEG Ratio―
Income Statement
In the last 12 months, Collegium Pharmaceutical had revenue of 631.45M and earned 69.19M in profits. Earnings per share was 2.14.
Revenue631.45M
Gross Profit377.34M
Operating Income169.90M
Pretax Income98.57M
Net Income69.19M
EBITDA341.70M
Earnings Per Share (EPS)2.14
Cash Flow
In the last 12 months, operating cash flow was 203.48M and capital expenditures -1.68M, giving a free cash flow of 201.81M billion.
Operating Cash Flow203.48M
Free Cash Flow201.81M
Free Cash Flow per Share6.41
Dividends & Yields
Collegium Pharmaceutical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.42
52-Week Price Change4.13%
50-Day Moving Average32.39
200-Day Moving Average30.44
Relative Strength Index (RSI)71.21
Average Volume (3m)359.27K
Important Dates
Collegium Pharmaceutical upcoming earnings date is Nov 6, 2025, TBA (Confirmed).
Last Earnings DateAug 7, 2025
Next Earnings DateNov 6, 2025
Ex-Dividend Date―
Financial Position
Collegium Pharmaceutical as a current ratio of 0.95, with Debt / Equity ratio of 360.11%
Current Ratio0.95
Quick Ratio0.88
Debt to Market Cap0.92
Net Debt to EBITDA2.31
Interest Coverage Ratio2.30
Taxes
In the past 12 months, Collegium Pharmaceutical has paid 29.38M in taxes.
Income Tax29.38M
Effective Tax Rate0.30
Enterprise Valuation
Collegium Pharmaceutical EV to EBITDA ratio is 5.01, with an EV/FCF ratio of 8.43.
EV to Sales2.71
EV to EBITDA5.01
EV to Free Cash Flow8.43
EV to Operating Cash Flow8.36
Balance Sheet
Collegium Pharmaceutical has $222.15M in cash and marketable securities with $829.11M in debt, giving a net cash position of $606.96M billion.
Cash & Marketable Securities$222.15M
Total Debt$829.11M
Net Cash$606.96M
Net Cash Per Share$19.27
Tangible Book Value Per Share-$25.56
Margins
Gross margin is 57.69%, with operating margin of 26.91%, and net profit margin of 10.96%.
Gross Margin57.69%
Operating Margin26.91%
Pretax Margin15.61%
Net Profit Margin10.96%
EBITDA Margin54.11%
EBIT Margin27.32%
Analyst Forecast
The average price target for Collegium Pharmaceutical is $43.75, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$43.75
Price Target Upside11.86% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast22.61%
EPS Growth Forecast-63.00%